Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

NCT02456480 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: CLS001
DRUG: Vehicle

Sponsor

Maruho Co., Ltd.